Kow, A. W. C. Hepatic metastasis from colorectal cancer. J. Gastrointest. Oncol. 10, 1274–1298 (2019).
Morgan, E. et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72, 338–344 (2023).
Siegel, R. L., Wagle, N. S. & Jemal, A. Leading cancer deaths in people younger than 50 years. JAMA 335, 632–634 (2026).
Nielsen, K., Rolff, H. C., Eefsen, R. L. & Vainer, B. The morphological growth patterns of colorectal liver metastases are prognostic for overall survival. Mod. Pathol. 27, 1641–1648 (2014).
Höppener, D. J. et al. Histopathological growth patterns and survival after resection of colorectal liver metastasis: an external validation study. JNCI Cancer Spectr. 5, pkab026 (2021).
Vermeulen, P. B. et al. Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J. Pathol. 195, 336–342 (2001).
Latacz, E. et al. Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights. Br. J. Cancer 127, 988–1013 (2022).
Höppener, D. J. et al. The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases. BMC Cancer 22, 911 (2022).
van Dam, P.-J. et al. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis. Br. J. Cancer 117, 1427–1441 (2017).
Bhattacharjee, S. et al. Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. J. Clin. Invest. 131, e146987 (2021).
Bocuk, D. et al. The adaptation of colorectal cancer cells when forming metastases in the liver: expression of associated genes and pathways in a mouse model. BMC Cancer 17, 342 (2017).
Frentzas, S. et al. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat. Med. 22, 1294–1302 (2016).
Fleischer, J. R. et al. Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution. Mol. Cancer 22, 17 (2023).
Elia, I. et al. Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. Nat. Commun. 8, 15267 (2017).
Pilley, S. E. et al. Loss of attachment promotes proline accumulation and excretion in cancer cells. Sci. Adv. 9, eadh2023 (2023).
Westbrook, R. L. et al. Proline synthesis through PYCR1 is required to support cancer cell proliferation and survival in oxygen-limiting conditions. Cell Rep. 38, 110320 (2022).
Buescher, J. M. et al. A roadmap for interpreting 13C metabolite labeling patterns from cells. Curr. Opin. Biotechnol. 34, 189–201 (2015).
Doglioni, G. et al. Aspartate signalling drives lung metastasis via alternative translation. Nature 638, 244–250 (2025).
Elia, I. et al. Breast cancer cells rely on environmental pyruvate to shape the metastatic niche. Nature 568, 117–121 (2019).
Lachmann, A. et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26, 2438–2444 (2010).
Latacz, E. et al. Molecular characterization of the histopathological growth patterns of colorectal cancer liver metastases by RNA sequencing of targeted samples at the tumor-liver interface. Clin. Exp. Metastasis 42, 1 (2025).
Han, H. et al. Small-molecule MYC inhibitors suppress tumor growth and enhance immunotherapy. Cancer Cell 36, 483–497.e15 (2019).
Vervoorts, J. et al. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 4, 484–490 (2003).
Altea-Manzano, P. et al. A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling. Nat. Cancer 4, 344–364 (2023).
Tabariès, S. et al. Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern. Commun. Biol. 4, 657 (2021).
Palmieri, V. et al. Neutrophils expressing lysyl oxidase-like 4 protein are present in colorectal cancer liver metastases resistant to anti-angiogenic therapy. J. Pathol. 251, 213–223 (2020).
Garralda, E. et al. MYC targeting by OMO-103 in solid tumors: a phase 1 trial. Nat. Med. 30, 762–771 (2024).
Schwartz, L. H. et al. RECIST 1.1-Update and clarification: From the RECIST committee. Eur. J. Cancer 62, 132–7 (2016).
Haghshomar, M. et al. Diagnostic accuracy of CT for the detection of hepatic steatosis: a systematic review and meta-analysis. Radiology 313, e241171 (2024).
Ophoff, D. et al. Liver fat and clinical outcomes in individuals with stage I-III colon or rectal cancer. J. Natl Cancer Inst. 188, 466–475 (2025).
Lee, K. S. et al. c-MYC copy-number gain is an independent prognostic factor in patients with colorectal cancer. PLoS ONE 10, e0139727 (2015).
Planque, M., Igelmann, S., Ferreira Campos, A. M. & Fendt, S.-M. Spatial metabolomics principles and application to cancer research. Curr. Opin. Chem. Biol. 76, 102362 (2023).
Demicco, M., Liu, X.-Z., Leithner, K. & Fendt, S.-M. Metabolic heterogeneity in cancer. Nat. Metab. 6, 18–38 (2024).
Santos, A. A. et al. Spatial metabolomics and its application in the liver. Hepatology 79, 1158–1179 (2024).
Lawson, D. A., Kessenbrock, K., Davis, R. T., Pervolarakis, N. & Werb, Z. Tumour heterogeneity and metastasis at single-cell resolution. Nat. Cell Biol. 20, 1349–1360 (2018).
Leduc, S. et al. Transcriptomic characterization of the histopathological growth patterns in breast cancer liver metastases. Clin. Exp. Metastasis 41, 699–705 (2024).
Calderaro, J. et al. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. J. Hepatol. 67, 727–738 (2017).
Terayama, N., Terada, T. & Nakanuma, Y. Histologic growth patterns of metastatic carcinomas of the liver. Jpn J. Clin. Oncol. 26, 24–29 (1996).
Camarda, R. et al. Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer. Nat. Med. 22, 427–432 (2016).
Casciano, J. C. et al. MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer. Br. J. Cancer 122, 868–884 (2020).
Yan, X. et al. Eugenol inhibits oxidative phosphorylation and fatty acid oxidation via downregulation of c-Myc/PGC-1β/ERRα signaling pathway in MCF10A-ras cells. Sci. Rep. 7, 12920 (2017).
Zhu, J. et al. Mitochondrial NADP(H) generation is essential for proline biosynthesis. Science 372, 968–972 (2021).
Schwörer, S. et al. Fibroblast pyruvate carboxylase is required for collagen production in the tumour microenvironment. Nat. Metab. 3, 1484–1499 (2021).
Schwörer, S. et al. Proline biosynthesis is a vent for TGFβ-induced mitochondrial redox stress. EMBO J. 39, EMBJ2019103334 (2020).
He, J., Fang, B., Shan, S. & Li, Q. Mechanical stiffness promotes skin fibrosis through Piezo1-mediated arginine and proline metabolism. Cell Death Discov. 9, 354 (2023).
Wu, J. et al. Glutamyl-prolyl-tRNA synthetase regulates proline-rich pro-fibrotic protein synthesis during cardiac fibrosis. Circ. Res. 127, 827–846 (2020).
Querejeta, R. et al. Increased collagen type I synthesis in patients with heart failure of hypertensive origin. Circulation 110, 1263–1268 (2004).
Staab-Weijnitz, C. A. Fighting the fiber: targeting collagen in lung fibrosis. Am. J. Respir. Cell Mol. Biol. 66, 363–381 (2022).
Leamy, A. K. et al. Enhanced synthesis of saturated phospholipids is associated with ER stress and lipotoxicity in palmitate treated hepatic cells. J. Lipid Res. 55, 1478–1488 (2014).
Subtil, B. et al. Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids. Front. Immunol. 14, 1105244 (2023).
Iyer, K. K. et al. High-dose short-term osimertinib treatment is effective in patient-derived metastatic colorectal cancer organoids. BJC Rep. 2, 29 (2024).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Anders, S., Pyl, P. T. & Huber, W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169 (2015).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15, 550 (2014).
Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv https://doi.org/10.1101/060012 (2016).
Kanehisa, M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27–30 (2000).
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
van Gorsel, M., Elia, I. & Fendt, S.-M. in Metabolic Signaling: Methods and Protocols 1st edn (eds Fendt, S.-M. & Lunt, S. Y.) 53–66 (Humana Press, 2019).
Lorendeau, D. et al. Dual loss of succinate dehydrogenase (SDH) and complex I activity is necessary to recapitulate the metabolic phenotype of SDH mutant tumors. Metab. Eng. 43, 187–197 (2017).
Vriens, K. et al. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity. Nature 566, 403–406 (2019).
Fernandez, C. A., Des Rosiers, C., Previs, S. F., David, F. & Brunengraber, H. Correction of 13C mass isotopomer distributions for natural stable isotope abundance. J. Mass Spectrom. 31, 255–262 (1996).
Stegen, S. et al. De novo serine synthesis regulates chondrocyte proliferation during bone development and repair. Bone Res. 10, 14 (2022).
R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2021).
Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).
Vennin, C. et al. Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. Sci. Transl. Med. 9, eaai8504 (2017).
Mehlem, A., Hagberg, C. E., Muhl, L., Eriksson, U. & Falkevall, A. Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nat. Protoc. 8, 1149–1154 (2013).
Neil, D. A. H. et al. Banff consensus recommendations for steatosis assessment in donor livers. Hepatology 75, 1014–1025 (2022).
van Buuren, S. & Groothuis-Oudshoorn, K. mice: multivariate imputation by chained equations in R. J. Stat. Softw. 45, 1–67 (2011).
Sjoberg, D. D., Whiting, K., Curry, M., Lavery, J. A. & Larmarange, J. Reproducible summary tables with the gtsummary package. R J. 13, 570–580 (2021).
Wasserthal, J. et al. TotalSegmentator: robust segmentation of 104 anatomic structures in CT images. Radiol. Artif. Intell. https://doi.org/10.1148/ryai.230024 (2023).
